Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeannine M Heckmann

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
Journal of the Neurological Sciences|September 3, 2022
A single low-dose rituximab infusion in severe chronic refractory myasthenia gravis in resource-limited settingsJeannine M Heckmann
Annals of the New York Academy of Sciences|October 7, 2017
A unique subphenotype of myasthenia gravisJeannine M Heckmann, Melissa Nel
Frontiers in Neurology|September 25, 2020
Management Issues in Myasthenia Gravis Patients Living With HIV: A Case Series and Literature ReviewJeannine M Heckmann, Suzaan Marais
Orphanet Journal of Rare Diseases|January 31, 2019
Profiling of patient-specific myocytes identifies altered gene expression in the ophthalmoplegic subphenotype of myasthenia gravisMelissa Nel, Sharon Prince, Jeannine M Heckmann
Journal of the Neurological Sciences|May 8, 2009
Opsoclonus-myoclonus syndrome and HIV-infectionKirsten M Scott, Faheema Parker, Jeannine M Heckmann
Orphanet Journal of Rare Diseases|December 14, 2020
Gene expression profiling of orbital muscles in treatment-resistant ophthalmoplegic myasthenia gravisTarin A Europa, Melissa Nel, Jeannine M Heckmann
Neuromuscular Disorders : NMD|April 29, 2019
A review of the histopathological findings in myasthenia gravis: Clues to the pathogenesis of treatment-resistance in extraocular musclesTarin A Europa, Melissa Nel, Jeannine M Heckmann
Muscle & Nerve|May 24, 2018
Myasthenic ophthalmoparesis: Time To resolution after initiating immune therapiesTarin A Europa, Melissa Nel, Jeannine M Heckmann
Neuromuscular Disorders : NMD|April 8, 2014
The effects of prednisone and steroid-sparing agents on decay accelerating factor (CD55) expression: implications in myasthenia gravisJennifer Auret, Amaal Abrahams, Sharon Prince, et al.
The Lancet. Neurology|February 19, 2013
Manifestations of HIV infection in the peripheral nervous systemChad M Centner, Kathleen J Bateman, Jeannine M Heckmann
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
Journal of the Neurological Sciences|September 3, 2022
A single low-dose rituximab infusion in severe chronic refractory myasthenia gravis in resource-limited settingsJeannine M Heckmann
Annals of the New York Academy of Sciences|October 7, 2017
A unique subphenotype of myasthenia gravisJeannine M Heckmann, Melissa Nel
Frontiers in Neurology|September 25, 2020
Management Issues in Myasthenia Gravis Patients Living With HIV: A Case Series and Literature ReviewJeannine M Heckmann, Suzaan Marais
Orphanet Journal of Rare Diseases|January 31, 2019
Profiling of patient-specific myocytes identifies altered gene expression in the ophthalmoplegic subphenotype of myasthenia gravisMelissa Nel, Sharon Prince, Jeannine M Heckmann
Journal of the Neurological Sciences|May 8, 2009
Opsoclonus-myoclonus syndrome and HIV-infectionKirsten M Scott, Faheema Parker, Jeannine M Heckmann
Orphanet Journal of Rare Diseases|December 14, 2020
Gene expression profiling of orbital muscles in treatment-resistant ophthalmoplegic myasthenia gravisTarin A Europa, Melissa Nel, Jeannine M Heckmann
Neuromuscular Disorders : NMD|April 29, 2019
A review of the histopathological findings in myasthenia gravis: Clues to the pathogenesis of treatment-resistance in extraocular musclesTarin A Europa, Melissa Nel, Jeannine M Heckmann
Muscle & Nerve|May 24, 2018
Myasthenic ophthalmoparesis: Time To resolution after initiating immune therapiesTarin A Europa, Melissa Nel, Jeannine M Heckmann
Neuromuscular Disorders : NMD|April 8, 2014
The effects of prednisone and steroid-sparing agents on decay accelerating factor (CD55) expression: implications in myasthenia gravisJennifer Auret, Amaal Abrahams, Sharon Prince, et al.
The Lancet. Neurology|February 19, 2013
Manifestations of HIV infection in the peripheral nervous systemChad M Centner, Kathleen J Bateman, Jeannine M Heckmann
Pageof 6